MarketCap
Facebook
X
TelegramAnnual report 2025
added 03-30-2026
Precipio Operating Cash Flow 2011-2026 | PRPO
Annual Operating Cash Flow Precipio
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 685 K | 439 K | -3.56 M | -7.72 M | -6.58 M | -7.43 M | -9.14 M | -6.75 M | -6.69 M | -959 K | -12.4 M | -13.7 M | -8.47 M | -10.2 M | 220 K |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 685 K | -13.7 M | -6.15 M |
Quarterly Operating Cash Flow Precipio
| 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| - | - | -44 K | - | - | - | -667 K | - | - | - | -1.58 M | - | -6.22 M | -3.98 M | -2.33 M | - | -5.14 M | -3.01 M | -1.26 M | - | -5.98 M | -3.56 M | -1.59 M | - | -7 M | -4.89 M | -1.88 M | - | -4.8 M | -3.61 M | -1.14 M | - | -4.48 M | -897 K | -326 K | - | -642 K | -390 K | -1.92 M | - | -9.44 M | -6.01 M | -3.51 M | - | -11.2 M | -7.26 M | -3.87 M | - | -6.33 M | -5.69 M | -3.33 M | - | -7.78 M | -5.2 M | -2.76 M | - | -899 K | 87 K | 51 K |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 87 K | -11.2 M | -3.6 M |
Operating Cash Flow of other stocks in the Diagnostics research industry
| Issuer | Operating Cash Flow | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Akumin
AKU
|
65.4 M | - | -17.87 % | $ 25.9 M |  Canada |
|
Centogene N.V.
CNTG
|
-21.7 M | - | -6.23 % | $ 30.6 M |  Germany |
 |
Agilent Technologies
A
|
1.48 B | $ 111.63 | -2.82 % | $ 33.9 B |  USA |
 |
Castle Biosciences
CSTL
|
64.9 M | $ 23.75 | -3.85 % | $ 660 M | USA |
 |
Accelerate Diagnostics
AXDX
|
-48.7 M | - | -61.36 % | $ 2.46 M | USA |
 |
Aspira Women's Health
AWH
|
-7.03 M | - | -6.19 % | $ 10.5 M | USA |
 |
Biocept
BIOC
|
-13.3 M | - | -13.05 % | $ 7.29 M | USA |
 |
Chembio Diagnostics
CEMI
|
-12.7 M | - | 0.22 % | $ 16.8 M | USA |
 |
Neogen Corporation
NEOG
|
58.2 M | $ 9.15 | -2.09 % | $ 1.98 B | USA |
 |
Check-Cap Ltd.
CHEK
|
-8 M | - | - | $ 9.42 M |  Israel |
 |
Co-Diagnostics
CODX
|
-29.1 M | $ 1.57 | -3.68 % | $ 2.09 M | USA |
 |
CareDx, Inc
CDNA
|
42 M | $ 18.76 | -14.38 % | $ 1 B | USA |
 |
Personalis
PSNL
|
-45.2 M | $ 5.14 | -6.64 % | $ 305 M | USA |
 |
DermTech
DMTK
|
-77 M | - | -11.32 % | $ 2.94 M | USA |
 |
Enzo Biochem
ENZ
|
-26.3 M | - | -8.98 % | $ 14.8 K | USA |
 |
Exact Sciences Corporation
EXAS
|
491 M | - | - | $ 19.8 B | USA |
 |
Fulgent Genetics
FLGT
|
21.1 M | $ 14.8 | -3.27 % | $ 447 M | USA |
 |
Illumina
ILMN
|
837 M | $ 122.36 | -3.59 % | $ 19.5 B | USA |
 |
Global Cord Blood Corporation
CO
|
614 M | - | - | $ 399 M |  China |
 |
Genetic Technologies Limited
GENE
|
-5.66 M | - | - | $ 7.1 B |  Australia |
 |
Genetron Holdings Limited
GTH
|
-524 M | - | 0.12 % | $ 80.1 M | China |
 |
Charles River Laboratories International
CRL
|
738 M | $ 164.68 | -1.27 % | $ 8.16 B | USA |
 |
HTG Molecular Diagnostics
HTGM
|
-18.4 M | - | -20.0 % | $ 1.06 M | USA |
 |
Trinity Biotech plc
TRIB
|
13.2 M | $ 0.6 | -1.75 % | $ 61.9 M |  Irlanda |
 |
Guardant Health
GH
|
-185 M | $ 80.74 | -2.83 % | $ 10.1 B | USA |
 |
Lantheus Holdings
LNTH
|
390 M | $ 80.56 | -3.58 % | $ 5.44 B | USA |
 |
Twist Bioscience Corporation
TWST
|
-47.6 M | $ 56.42 | -4.62 % | $ 3.37 B | USA |
 |
Heska Corporation
HSKA
|
-21.8 M | - | - | $ 1.31 B | USA |
 |
Interpace Biosciences
IDXG
|
5.83 M | $ 1.99 | 2.9 % | $ 8.8 M | USA |
 |
Senseonics Holdings
SENS
|
-59.1 M | $ 6.61 | -7.94 % | $ 276 M | USA |
 |
QIAGEN N.V.
QGEN
|
654 M | - | - | $ 10.6 B |  Niderland |
 |
Medpace Holdings
MEDP
|
713 M | $ 414.07 | 1.05 % | $ 11.9 B | USA |
 |
Biomerica
BMRA
|
-3.84 M | $ 2.16 | -1.22 % | $ 4.96 M | USA |
 |
Motus GI Holdings
MOTS
|
-11.2 M | - | -34.28 % | $ 263 K | Israel |
 |
ICON Public Limited Company
ICLR
|
1.29 B | $ 117.5 | 14.65 % | $ 9.69 B | Irlanda |
 |
Laboratory Corporation of America Holdings
LH
|
1.64 B | $ 256.65 | -1.12 % | $ 21.4 B | USA |
 |
NeoGenomics
NEO
|
5.23 M | $ 8.49 | -5.88 % | $ 1.09 B | USA |
 |
Celcuity
CELC
|
-153 M | $ 117.01 | -2.55 % | $ 5.47 B | USA |
 |
National Research Corporation
NRC
|
26.4 M | $ 15.61 | -7.33 % | $ 349 M | USA |
 |
Myriad Genetics
MYGN
|
1.8 M | $ 4.62 | -4.55 % | $ 428 M | USA |
 |
Natera
NTRA
|
-432 M | $ 192.71 | -3.73 % | $ 19 B | USA |
 |
Quest Diagnostics Incorporated
DGX
|
1.89 B | $ 190.26 | -2.46 % | $ 21.1 B | USA |
 |
Invitae Corporation
NVTA
|
-493 M | - | - | $ 21.2 M | USA |
 |
Burning Rock Biotech Limited
BNR
|
-478 M | $ 16.15 | -2.99 % | $ 174 M | China |
 |
OpGen
OPGN
|
-4.87 M | - | -16.95 % | $ 1.54 M | USA |
 |
Organovo Holdings
ONVO
|
-9.46 M | - | -2.3 % | $ 19.4 M | USA |